Lonza Group
Swiss pharmaceutical and biotech company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Lonza Group?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.
Quick Facts Company type, Traded as ...
Company type | Aktiengesellschaft |
---|---|
SIX: LONN SGX: O6Z SMI component | |
ISIN | CH0013841017 |
Industry | Pharmaceuticals biotechnology |
Founded | 1897 |
Headquarters | Basel, Switzerland |
Key people | Albert M. Baehny (Ad-interim CEO) |
Products | Biopharmaceuticals |
Revenue | CHF 4.508 billion (2021)[1] |
CHF 1.665 billion (2021)[1] | |
Total assets | CHF 16.459 billion (end 2021)[1] |
Total equity | CHF 9.823 billion (end 2021)[1] |
Number of employees | 17,500 (2023) |
Website | www.lonza.com |
Close